MIMEDX GROUP INC - COMMON STOCK

New Study Demonstrates Potential for MIMEDX Purion® Processed Dehydrated Human Amnion/Chorion Membrane to Modulate Pathological Scar Tissue Formation

15 Jun 2021 15:54:18 By Nasdaq GlobeNewswire

MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan

08 Jun 2021 07:30:00 By Nasdaq GlobeNewswire

MIMEDX to Participate at the Jefferies Virtual Healthcare Conference

27 May 2021 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of Shareholders

25 May 2021 07:30:00 By Nasdaq GlobeNewswire

MIMEDX Reminds Shareholders to Vote at the Upcoming Annual Meeting

12 May 2021 07:00:02 By Nasdaq GlobeNewswire

MIMEDX to Participate at Upcoming Investor Conferences

10 May 2021 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Announces Collaborative Agreement with the Wake Forest Institute for Regenerative Medicine

06 May 2021 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Urges Shareholders to Consider Prescience Point’s Motivations Before Voting Their Shares at the Company’s Annual Meeting

04 May 2021 08:15:29 By Nasdaq GlobeNewswire

MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders

03 May 2021 07:02:38 By Nasdaq GlobeNewswire

MiMedx Announces First Quarter 2021 Financial and Operating Results

28 Apr 2021 16:00:00 By Nasdaq GlobeNewswire

MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice President, Quality Assurance and Regulatory Affairs

28 Apr 2021 09:21:42 By Nasdaq GlobeNewswire

MiMedx to Host First Quarter 2021 Operating and Financial Results Conference Call on April 29

22 Apr 2021 07:00:02 By Nasdaq GlobeNewswire

MiMedx Announces Last Patients Last Visits in Three Late-Stage Musculoskeletal Trials with Proprietary Tissue Technology

19 Apr 2021 08:00:00 By Nasdaq GlobeNewswire

MiMedx Confirms Receipt of Director Nominations from Prescience Point Capital Management

16 Apr 2021 11:06:56 By Nasdaq GlobeNewswire

MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program

30 Mar 2021 07:00:01 By Nasdaq GlobeNewswire

MiMedx Announces Appointment of Phyllis Gardner, M.D. to Board of Directors

08 Mar 2021 16:33:24 By Nasdaq GlobeNewswire

MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results

08 Mar 2021 16:32:17 By Nasdaq GlobeNewswire

MiMedx to Participate at Upcoming Investor Conferences

03 Mar 2021 07:00:01 By Nasdaq GlobeNewswire

MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9

02 Mar 2021 07:00:05 By Nasdaq GlobeNewswire

MiMedx to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

10 Feb 2021 07:00:00 By Nasdaq GlobeNewswire